| Participating centers | Recruitment period | Number of patients | IAP (mmHg) | Type of NMBb | Type of anesthesia | Gender N (%) | ASA classification N (%) | Age Mean (SD) | BMI Mean (SD) | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | 1 | 2 | 3 | |||||||||
Warle et al. (2013) | RUMC | 2011–2012 | 20 | 7 vs 14 | TOF 1–2 | TIVA | 10 (50.0%) | 10 (50.0%) | 17 (85%) | 3 (15%) | 0 (0%) | 51.15 (±9.33) | 25.32 (±3.21) |
Ozdemir-Van Brunschot et al. (2017) | RUMC | 2014–2015 | 64 | 6 vs 12 | PTC 1–5 | Volatile | 36 (56.3%) | 28 (43.8%) | 44 (69%) | 20 (31%) | 0 (0%) | 54.94 (±12.04) | 25.92 (±3.19) |
Ozdemir-Van Brunschot et al. (2018) | RUMC | 2015–2016 | 34 | 6 | TOF 1–2 vs PTC 1–5 | Volatile | 22 (64.7%) | 23 (35.3%) | N/A | N/A | N/A | 50.19 (±12.49) | 25.54 (±3.74) |
Bruintjes et al. (2019) | RUMC LUMC | 2016–2017 | 96 | 12 | “Single-dose” vs PTC 1–2 | TIVA | 45 (46.9%) | 51 (53.1%) | 61 (64%) | 35 (36%) | 0 (0%) | 56.14 (±9.90) | 26.46 (±2.99) |
Klop et al. (2014) | EMCR | 2011–2012 | 20a | 14 | “Single-dose” | TIVA | 5 (25.0%) | 15 (75.0%) | 14 (70%) | 5 (25%) | 1 (5%) | 49.72 (±14.39) | 25.09 (±3.19) |
Dols et al. (2014) | EMCR | 2008–2010 | 95a | 14 | “Single-dose” | TIVA | 39 (41.1%) | 56 (58.9%) | 59 (62%) | 35 (37%) | 1 (1%) | 51.59 (±12.99) | 25.96 (±4.13) |
Dols et al. (2010) | EMCR RUMC | 2006–2008 | 40 | 12 | “Single-dose” | TIVA | 24 (60.0%) | 16 (40.0%) | 29 (73%) | 11 (28%) | 0 (0%) | 53.41 (±9.62) | 26.94 (±3.78) |
Minnee et al. (2008) | AUMC | 2002–2006 | 105 | 12 | “Single-dose” | TIVA | 44 (41.9%) | 61 (58.1%) | 85 (81%) | 20 (19%) | 0 (0%) | 47.73 (±11.86) | 25.61 (±3.57) |
EMCR | 2001–2004 | 49a | 12 | “Single-dose” | TIVA | 25 (51.0%) | 24 (49.0%) | 39 (80%) | 10 (20%) | 0 (0%) | 49.40 (±14.73) | 25.73 (±3.57) | |
EMCR RUMC | 2001–2004 | 50a | 12 | “Single-dose” | TIVA | 18 (52.9%) | 16 (47.1%) | N/A | N/A | N/A | 47.31 (±13.23) | 26.13 (±4.45) |